Search
for
Sort by
Research 571–600 of 1000+
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
- BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer
- European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
- Budesonide for maintenance of remission in Crohn's disease
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- The Role of Vitamins and Minerals in Hair Loss: A Review
- The use of cyclosporine in dermatology: Part I
- Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- New Antifungal Agents and New Formulations Against Dermatophytes
- A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth
- Topical Ruxolitinib for the Treatment of Alopecia Universalis
- Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials
- Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata
- Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology
- JAK Inhibitors for Treatment of Alopecia Areata
- Features Associated With Quality of Life Impairment in Hidradenitis Suppurativa Patients
- Hypogonadism as a Reversible Cause of Torsades de Pointes in Men
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Hyperaldosteronism and Hyperprogesteronism in a Cat
- Alopecia areata after dupilumab for atopic dermatitis
- Methotrexate for induction of remission in ulcerative colitis
- Effects of aromatase inhibitors on human osteoblast and osteoblast-like cells: A possible androgenic bone protective effects induced by exemestane
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Alopecia With Endocrine Therapies in Patients With Cancer